eMedicine Specialties > Dermatology > Diseases of the Oral Mucosa

Cheilitis Glandularis: Treatment & Medication

Author: Ellen Eisenberg, DMD, Professor, Section Chair and Director, Oral and Maxillofacial Pathology, Oral Pathology Biopsy Service, Department of Oral Health and Diagnostic Sciences; Associate Professor, Division of Anatomic Pathology, Department of Pathology and Laboratory Medicine, University of Connecticut Health Center
Contributor Information and Disclosures

Updated: Dec 31, 2008

Treatment

Medical Care

The approach to treatment is based on diagnostic information obtained from histopathologic analysis, the identification of likely etiologic factors responsible for the condition, and attempts to alleviate or eradicate those causes. Given the relatively small number of reported cases of cheilitis glandularis, neither sufficient nor reliable data exist with regard to medical approaches to the condition. Therefore, treatment varies accordingly for each patient.

  • For cases attributable to angioedema, administration of an antihistamine may effect temporary reduction in acute nonpurulent swelling.
  • Suppurative cases of cheilitis glandularis require management with appropriate antimicrobial treatment as determined by culture and sensitivity testing. Concomitant intralesional or oral corticosteroid treatment may potentiate the effectiveness of antimicrobial therapy in cases with nodularity; however, the potential systemic adverse effects of long-term corticosteroid treatment, plus its propensity for promoting local fibrosis and scarring, limit its potential use either as an adjunct to antibiotic treatment or as a single therapeutic modality for cheilitis glandularis.
  • Topical 5-fluorouracil is useful for treatment of dysplastic actinic cheilitis and to curtail its progression. In conjunction with clinical supervision, it can be prescribed as an alternative to vermilionectomy or as a prophylactic measure following vermilionectomy.

Surgical Care

In cases in which a history of chronic sun exposure exists (especially if the patient is fair skinned or the everted lip surface is chronically eroded, ulcerated, or crusted), biopsy is strongly recommended to rule out actinic cheilitis or carcinoma.

  • Surgical excision is not necessary when the diagnosis is actinic cheilitis with atypia or only mild dysplasia; however, patients require ongoing clinical vigilance at regular intervals and instruction in measures to protect the lips from further sun damage.
  • Treatment options for cases of actinic cheilitis with moderate-to-severe dysplasia include surgical stripping or vermilionectomy, cryosurgery or laser surgery, or topical chemotherapy with 5-fluorouracil. Given the potential for recurrence and the risk for development of carcinoma, sun protective measures and regular clinical monitoring must be instituted.
  • Carcinoma of the vermilion is treated with surgical wedge resection with adequate margins or vermilionectomy. A palpatory examination of the submental lymph nodes is indicated to rule out regional metastasis.
  • In cases in which eversion, extensive fibrosis, and induration have resulted in lip incompetence with functional and cosmetic compromise, chronic pain, and surface disruption, debulking with surgical cheiloplasty is indicated to restore normal lip architecture and function. Cheiloplasty is also a prophylactic measure for reducing the risk of actinic injury.

Consultations

  • Consultation with the patient's other providers regarding the possibility of prescribing alternative, less desiccating medications is indicated in cases where medication-induced xerostomia is believed to be contributory to or causative of lip dryness.
  • Patients with angioedema or atopic dermatitis (cheilitis) with or without a personal or family history of allergic rhinitis, asthma, or urticaria could benefit from consultation with an allergist-immunologist.
  • Psychiatric consultation is recommended in cases where psychogenic factors appear to be contributory. Clinical and historical evidence or suspicion of deliberate, self-inflicted injury to the lip (Munchausen syndrome) should prompt referral for a psychiatric evaluation, particularly if a surgical treatment approach is being considered.16

Medication

For cases attributable to angioedema, administration of an antihistamine may effect temporary reduction in acute nonpurulent swelling. Suppurative cases of cheilitis glandularis require management with appropriate antimicrobial treatment as determined by culture and sensitivity testing. Concomitant intralesional or oral corticosteroid treatment may potentiate the effectiveness of antimicrobial therapy in cases with significant nodularity; however, potential systemic adverse effects of long-term corticosteroid treatment, plus propensity for promoting local fibrosis and scarring, limit its potential use either as an adjunct to antibiotic treatment or as a single therapeutic modality for cheilitis glandularis.

Topical 5-fluorouracil is useful for the treatment of dysplastic actinic cheilitis and to curtail its progression. In conjunction with clinical supervision, it can be prescribed as an alternative to vermilionectomy or as a prophylactic measure following vermilionectomy.

Antihistamines

These agents are used to treat angioedema or suspected allergic reaction.


Diphenhydramine (Benadryl)

For symptomatic relief of symptoms caused by release of histamine in allergic reactions.

Adult

25-50 mg PO q6-8h prn for 48 h; not to exceed 300 mg/d
Alternatively, 10-50 mg IM/IV q2-3h; not to exceed 400 mg/d

Pediatric

<6 years: 6.25-12.5 mg PO q4-6h
6-12 years: 12.5-25 mg PO q4-6h; not to exceed 150 mg/d
>12 years: Administer as in adults

Potentiates effect of CNS depressants; because of alcohol content, do not give syr dosage form to patient taking medications that can cause disulfiramlike reactions; concomitant alkaloids present in belladonna, antidepressants with strong anticholinergic effects (eg, amitriptyline, trimipramine, amoxapine, doxepin, imipramine, nortriptyline, maprotiline), or phenothiazines with strong anticholinergic effects (eg, chlorpromazine, triflupromazine, thioridazine) and antihistamines may increase possibility of adynamic ileus, urinary retention, or chronic glaucoma (more prominent in elderly patients)

Documented hypersensitivity; acute asthma; newborns; breastfeeding

Pregnancy

B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals

Precautions

May exacerbate angle-closure glaucoma, hyperthyroidism, peptic ulcer, and urinary tract obstruction; elderly persons more susceptible to adverse effects; caution in history of bronchial asthma, cardiovascular disease or hypertension; may cause excitation in young children

Pyrimidine antagonists

These agents are used to treat actinic cheilitis (dysplastic).


Fluorouracil (Efudex, Fluoroplex, Carac)

Interferes with DNA synthesis by blocking methylation of deoxyuridylic acid, inhibiting thymidylate synthetase and subsequently cell proliferation. Topical forms approved for actinic keratoses; only 5% (Efudex) form approved for superficial basal cell carcinoma.

Adult

Apply 0.5-5% strength thinly to affected area qd/bid for 2-4 wk

Pediatric

Not established

Documented hypersensitivity; potentially serious infections

Pregnancy

X - Contraindicated; benefit does not outweigh risk

Precautions

Inflammatory reactions may occur with use of occlusive dressings; porous gauze dressing may be applied for cosmetic reasons without increase in reaction; patients should expect inflammatory reaction with crusting; because contraindicated for use on mucous membranes, cream rather than liquid form is preferable for use on vermilion surface; duration of application to lip may be shorter than on skin because of its propensity to induce intense inflammatory responses

Corticosteroids

These agents have anti-inflammatory properties and cause profound and varied metabolic effects. They modify the body's immune response to diverse stimuli.


Prednisone (Deltasone, Orasone)

Immunosuppressant for treatment of autoimmune disorders; may decrease inflammation by reversing increased capillary permeability and suppressing PMN activity. Stabilizes lysosomal membranes and also suppresses lymphocyte and antibody production. Single morning dose is safer for long-term use, but divided doses have more anti-inflammatory effect.

Adult

0.5-2 mg/kg/d (around 1 mg/kg/d) PO; taper as condition improves

Pediatric

Administer as in adults but dose more around 1-2 mg/kg/d range

Coadministration with estrogens may decrease clearance; when used with digoxin, digitalis toxicity secondary to hypokalemia may increase; phenobarbital, phenytoin, and rifampin may increase the metabolism of glucocorticoids (consider increasing maintenance dose); monitor for hypokalemia with coadministration of diuretics; coadministration with ritonavir may significantly increase serum concentrations of prednisone; concomitant therapy with montelukast may result in severe peripheral edema; clarithromycin may increase risk of psychotic symptoms

Documented hypersensitivity; viral, fungal, tubercular skin, or connective tissue infections; peptic ulcer disease; hepatic dysfunction; GI disease

Pregnancy

B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals

Precautions

May unmask hypertension or diabetes or exacerbate peptic ulcer disease and tuberculosis; long-term sequelae associated with long-term steroid use include osteoporosis, cataracts, and pituitary-hypothalamic axis suppression; with high doses, patients may develop a steroid psychosis and are at increased risk of infections, particularly when oral steroids are used in conjunction with other immunosuppressants; frequently monitor patient's blood glucose level, blood pressure, and weight; monitor for Cushing syndrome
In cheilitis glandularis, persistent swelling or increasing nodularity are indications for ceasing intralesional or PO use

More on Cheilitis Glandularis

Overview: Cheilitis Glandularis
Differential Diagnoses & Workup: Cheilitis Glandularis
Treatment & Medication: Cheilitis Glandularis
Follow-up: Cheilitis Glandularis
Multimedia: Cheilitis Glandularis
References

References

  1. Neville BW, Damm DD, Allen CA, Bouquot JE. Salivary Gland Pathology. In: Neville BW, Damm DD, Allen CA, Bouquot JE, eds. Oral and Maxillofacial Pathology. 3rd ed. St Louis, Mo: Saunders Elsevier; 2009:462-3.

  2. von Volkman R. Einege Falle von Cheilitis Glandularis Apostematosa (Myxadenitis Labialis). Virchows Arch Pathol Anat [A]. 1870;50:142-4.

  3. Sutton RL. Cheilitis glandularis apostematosa (with case report). J Cutan Dis. 1909;27:151-4.

  4. Sutton RL. The symptomatology and treatment of three common diseases of the vermilion border of the lip. Int Clin (series 24). 1914;3:123-8.

  5. Swerlick RA, Cooper PH. Cheilitis glandularis: a re-evaluation. J Am Acad Dermatol. Mar 1984;10(3):466-72. [Medline].

  6. Stoopler ET, Carrasco L, Stanton DC, Pringle G, Sollecito TP. Cheilitis glandularis: an unusual histopathologic presentation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. Mar 2003;95(3):312-7. [Medline].

  7. Musa NJ, Suresh L, Hatton M, Tapia JL, Aguirre A, Radfar L. Multiple suppurative cystic lesions of the lips and buccal mucosa: a case of suppurative stomatitis glandularis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. Feb 2005;99(2):175-9. [Medline].

  8. Reichart PA, Scheifele Ch, Philipsen HP. [Glandular cheilitis. 2 case reports]. Mund Kiefer Gesichtschir. Jul 2002;6(4):266-70. [Medline].

  9. Leao JC, Ferreira AM, Martins S, Jardim ML, Barrett AW, Scully C, et al. Cheilitis glandularis: An unusual presentation in a patient with HIV infection. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. Feb 2003;95(2):142-4. [Medline].

  10. Butt FM, Chindia ML, Rana FS, Ashani A. Cheilitis glandularis progressing to squamous cell carcinoma in an hiv-infected patient: case report. East Afr Med J. Dec 2007;84(12):595-8. [Medline].

  11. Carrington PR, Horn TD. Cheilitis glandularis: a clinical marker for both malignancy and/or severe inflammatory disease of the oral cavity. J Am Acad Dermatol. Feb 2006;54(2):336-7. [Medline].

  12. Parmar RC, Muranjan MN. A newly recognized syndrome with double upper and lower lip, hypertelorism, eyelid ptosis, blepharophimosis, and third finger clinodactyly. Am J Med Genet A. Jan 15 2004;124A(2):200-1. [Medline].

  13. Cohen DM, Green JG, Diekmann SL. Concurrent anomalies: cheilitis glandularis and double lip. Report of a case. Oral Surg Oral Med Oral Pathol. Sep 1988;66(3):397-9. [Medline].

  14. Dhanapal R, Nalin Kumar S, Saraswathi TR, Uma Devi M, Joshua E, Veerabahu M, et al. Maxillary double lip and cheilitis glandularis: An unusual occurence. J Oral Maxillofac Pathol. 2007;11:35-7. [Full Text].

  15. Bender MM, Rubenstein M, Rosen T. Cheilitis glandularis in an African-American woman: response to antibiotic therapy. Skinmed. Nov-Dec 2005;4(6):391-2. [Medline].

  16. Michalowski R. Munchausen's syndrome: a new variety of bleeding type-self-inflicted cheilorrhagia and cheilitis glandularis. Dermatologica. 1985;170(2):93-7. [Medline].

  17. Aydin E, Gokoglu O, Ozcurumez G, Aydin H. Factitious cheilitis: a case report. J Med Case Reports. Jan 29 2008;2:29. [Medline].

  18. Erkek E, Sahin S, Kilic R, Erdogan S. A case of cheilitis glandularis superimposed on oral lichen planus: successful palliative treatment with topical tacrolimus and pimecrolimus. J Eur Acad Dermatol Venereol. Aug 2007;21(7):999-1000. [Medline].

  19. Hillen U, Franckson T, Goos M. Cheilitis glandularis: a case report. Acta Derm Venereol. 2004;84(1):77-9. [Medline].

  20. Jensen JL. Idiopathic diseases. In: Ellis GL, AuClair PL, Gnepp DR, eds. Major Problems in Pathology. Vol 2. Philadelphia, Pa: WB Saunders; 1991:79.

  21. Kaugars GE, Pillion T, Svirsky JA, Page DG, Burns JC, Abbey LM. Actinic cheilitis: a review of 152 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. Aug 1999;88(2):181-6. [Medline].

  22. Lederman DA. Suppurative stomatitis glandularis. Oral Surg Oral Med Oral Pathol. Sep 1994;78(3):319-22. [Medline].

  23. Lourenco SV, Gori LM, Boggio P, Nico MM. Cheilitis glandularis in albinos: a report of two cases and review of histopathological findings after therapeutic vermilionectomy. J Eur Acad Dermatol Venereol. Oct 2007;21(9):1265-7. [Medline].

  24. Rogers RS 3rd, Bekic M. Diseases of the lips. Semin Cutan Med Surg. Dec 1997;16(4):328-36. [Medline].

  25. Shapiro PE. Noninfectious granulomas. In: Elder D, Elenitsas R, Jaworsky C, Johnson B eds. Lever's Histopathology of the Skin. 8th ed. Philadelphia, Pa: Lippincott-Raven; 1997:327-8.

  26. Winchester L, Scully C, Prime SS, Eveson JW. Cheilitis glandularis: a case affecting the upper lip. Oral Surg Oral Med Oral Pathol. Dec 1986;62(6):654-6. [Medline].

  27. Yacobi R, Brown DA. Cheilitis glandularis: a pediatric case report. J Am Dent Assoc. Mar 1989;118(3):317-8. [Medline].

Further Reading

Keywords

cheilitis glandularis, CG, suppurative sialadenitis, suppurative stomatitis glandularis, actinic cheilitis, squamous cell carcinoma, myxadenitis labialis, cheilitis apostematosa, Baelz disease, Baelz's disease

Contributor Information and Disclosures

Author

Ellen Eisenberg, DMD, Professor, Section Chair and Director, Oral and Maxillofacial Pathology, Oral Pathology Biopsy Service, Department of Oral Health and Diagnostic Sciences; Associate Professor, Division of Anatomic Pathology, Department of Pathology and Laboratory Medicine, University of Connecticut Health Center
Ellen Eisenberg, DMD is a member of the following medical societies: American Academy of Oral and Maxillofacial Pathology
Disclosure: Nothing to disclose.

Medical Editor

Mark W Cobb, MD, Consulting Staff, WNC Dermatological Associates
Mark W Cobb, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, and American Society of Dermatopathology
Disclosure: Nothing to disclose.

Pharmacy Editor

Michael J Wells, MD, Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center
Michael J Wells, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, and Texas Medical Association
Disclosure: Nothing to disclose.

Managing Editor

Drore Eisen, MD, DDS, Consulting Staff, Department of Dermatology, Dermatology Research Associates of Cincinnati
Drore Eisen, MD, DDS is a member of the following medical societies: American Academy of Dermatology, American Academy of Oral Medicine, and American Dental Association
Disclosure: Nothing to disclose.

CME Editor

Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University
Catherine Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology
Disclosure: Nothing to disclose.

Chief Editor

William D James, MD, Paul R Gross Professor of Dermatology, University of Pennsylvania School of Medicine; Vice-Chair, Program Director, Department of Dermatology, University of Pennsylvania Health System
William D James, MD is a member of the following medical societies: American Academy of Dermatology and Society for Investigative Dermatology
Disclosure: elsevier Royalty Other; american college of physicians Honoraria Other

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.